Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
NTR · NYSE · United States · Agricultural Chemicals
In shortNutrien Ltd. is profitable, generates cash and carries moderate debt, with revenue growing (+3.5% last year).
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 13.9% | 63/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 8.4% | 54/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 9.1% | 46/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 7.9% | 53/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.34× | 45/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.40× | 89/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.56× | 70/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 5.44× | 38/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.68 | 41/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 7.9% | 52/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.94× | 80/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 26.3% | 14/100 |
| Operating margin volatility | 8.4% | 33/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -10.8% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | -31.0% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 27,712 | 37,884 | 29,056 | 25,972 | 26,885 |
| Cost of revenue | 17,452 | 21,588 | 19,608 | 17,486 | 17,602 |
| Gross profit | 9,409 | 15,424 | 8,474 | 7,530 | 8,347 |
| Operating income | 4,781 | 10,809 | 2,745 | 1,856 | 3,736 |
| Interest expense | 613 | 563 | 793 | 720 | 687 |
| Pre-tax income | 4,168 | 10,246 | 1,952 | 1,136 | 3,049 |
| Income tax | 989 | 2,559 | 670 | 436 | 752 |
| Net income | 3,153 | 7,660 | 1,258 | 674 | 2,267 |
| Diluted EPS | $5.52 | $14.18 | $2.53 | $1.36 | $4.66 |
| Diluted shares (millions) | 571 | 540 | 497 | 494 | 487 |
4 older years available with the 10-year history. Essential plan, from €8.25/month →
2.68 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
8/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Feb 27, 2026